Celularity adds Viome CEO Naveen Jain to board; Diane Parks resigns; fifth director expected

Celularity Inc

Naveen Jain, founder and CEO of Viome Life Sciences, appointed to Celularity's board, effective once the Rule 14f-1 information statement process completes.
Director Diane Parks resigned effective at that same time; Celularity said her decision was not the result of any disagreement over operations, policies or practices.
Jain's seat comes from board designation rights granted to investors in the September 2026 financing, previously disclosed in the Form 8-K filed September 28, 2026.
Board now consists of CEO Robert J. Hariri, Peter H. Diamandis, Philip A. Barach and Jain; Celularity said it expects to announce a fifth director shortly.
Jain receives standard non-employee director compensation, is expected to sign the company's standard indemnification agreement, and has no initial committee assignments.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.